DYNE THERAPEUTICS INC
DYNNASDAQ🏆 #1688 by market capEarnings Oct 29US Equity
$16.52▲ $0.32 (+1.93%)
LiveTrack DYN
Get earnings, price moves & breaking news on Telegram
24h▲ 1.9%
7d▲ 1.9%
14d▼ 4.5%
30d▼ 35.0%
ytd▼ 15.5%
1y▲ 30.7%
🏦Market Cap
$3.09B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
52
Weak
DYNE THERAPEUTICS INC
DYNAnalyst Ratings
Price
$16.52
Total
14
Raised
2
Lowered
1
Avg PT
$35.00
H / L
$50 / $24
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Piper Sandler | Reiterated | Overweight | 2026-09-29 | $47.00 | +184.40% |
JP Morgan | Downgraded | Neutral → Underweight | 2026-09-09 | $18.00 | +8.90% |
Morgan Stanley | Reiterated | Overweight | 2026-09-09 | $36.00 | +117.90% |
RBC Capital | Reiterated | Outperform | 2026-09-09 | $30.00 | +81.60% |
Baird | Reiterated | Outperform | 2026-09-09 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-05-15 | — | — |
Bernstein | Reiterated | Market Perform | 2026-05-13 | $24.00 | +45.20% |
Chardan Capital | Reiterated | Buy | 2026-03-09 | $38.00 | +130.00% |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-03 | — | — |
Stifel | Reiterated | Buy | 2025-12-11 | — | — |
Oppenheimer | Upgraded | Perform → Outperform | 2025-12-10 | $40.00 | +142.10% |
Raymond James | Upgraded | Outperform → Strong Buy | 2025-08-25 | $37.00 | +123.90% |
Guggenheim | Reiterated | Buy | 2025-06-18 | — | — |
Jefferies | Reiterated | Buy | 2024-05-20 | $50.00 | +202.60% |
Institution
Piper Sandler
Reiterated · Overweight · 2026-09-29
$47.00
+184.40%
JP Morgan
Downgraded · Neutral → Underweight · 2026-09-09
$18.00
+8.90%
Morgan Stanley
Reiterated · Overweight · 2026-09-09
$36.00
+117.90%
RBC Capital
Reiterated · Outperform · 2026-09-09
$30.00
+81.60%
Baird
Reiterated · Outperform · 2026-09-09
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-05-15
—
—
Bernstein
Reiterated · Market Perform · 2026-05-13
$24.00
+45.20%
Chardan Capital
Reiterated · Buy · 2026-03-09
$38.00
+130.00%
HC Wainwright & Co.
Reiterated · Buy · 2026-03-03
—
—
Stifel
Reiterated · Buy · 2025-12-11
—
—
Oppenheimer
Upgraded · Perform → Outperform · 2025-12-10
$40.00
+142.10%
Raymond James
Upgraded · Outperform → Strong Buy · 2025-08-25
$37.00
+123.90%
Guggenheim
Reiterated · Buy · 2025-06-18
—
—
Jefferies
Reiterated · Buy · 2024-05-20
$50.00
+202.60%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space